TDs / Ken O'Flynn

Official portrait of Ken O'Flynn

Ken O'Flynn

Independent Ireland Cork North-Central TD in this Dáil since 29 November 2024

Official Oireachtas profile

Portrait: © Houses of the Oireachtas (Oireachtas (Open Data) PSI Licence) · source file

9,005
questions asked
Oral and written, to government departments
86,377
words spoken in the chamber
Across 393 contributions. Plus 40 contributions from the chair, not counted
295
votes recorded
Each Yes, No or Abstained in a recorded vote
421
topics asked about
Across 20 departments

From the Dáil chamber only: committee meetings are not in this archive.

What they ask about

The subject headings the Oireachtas filed their questions under.

Who they ask

The departments their questions were addressed to.

Month by month

Low months are usually recesses, when the Dáil does not sit. The archive runs to 22 October 2026.

Questions asked 9,005 in all

Dec 2024Oct 2026

Contributions to debates 393 in all

Dec 2024Oct 2026
Show as a table
MonthQuestionsContributions
December 2024 0 1
January 2025 0 1
February 2025 17 20
March 2025 14 22
April 2025 24 16
May 2025 227 18
June 2025 49 14
July 2025 35 24
August 2025 0 0
September 2025 663 33
October 2025 297 9
November 2025 1,060 18
December 2025 621 2
January 2026 190 45
February 2026 911 14
March 2026 387 38
April 2026 691 31
May 2026 2,122 20
June 2026 635 22
July 2026 289 11
August 2026 0 2
September 2026 347 12
October 2026 426 20

Debates they spoke in most

Plus 188 contributions in the regular slots, such as Leaders' Questions and Priority Questions. Speech from the chair is not counted.

Asked about similar topics

Worked out by computer from the subject headings of each TD's questions, giving more weight to headings few TDs use. It shows shared subjects, not shared views.

Party, constituency and offices

  1. constituency Cork North-Central 29 November 2024 to now
  2. party Independent Ireland 29 November 2024 to now
Ken O'Flynn Written 26 May 2026 · to Health
1289. Deputy Ken O'Flynn asked the Minister for Health whether any central register exists recording the total annual cost per treatment category funded under the treatment abroad scheme. [39191/26]
Ken O'Flynn Written 26 May 2026 · to Health
1290. Deputy Ken O'Flynn asked the Minister for Health whether the HSE records clinical outcomes, complication rates or patient satisfaction data in respect of procedures funded under the treatment abroad scheme. [39192/26]
Ken O'Flynn Written 26 May 2026 · to Health
1291. Deputy Ken O'Flynn asked the Minister for Health whether the Department of Health has carried out any review assessing whether certain procedures regularly funded abroad under the treatment abroad scheme could be developed domestically within the public health system. [39193/26]
Ken O'Flynn Written 26 May 2026 · to Health
1292. Deputy Ken O'Flynn asked the Minister for Health whether any maximum financial approval thresholds apply under the treatment abroad scheme before additional senior management or Departmental approval is required. [39194/26]
Ken O'Flynn Written 26 May 2026 · to Health
1293. Deputy Ken O'Flynn asked the Minister for Health whether the Comptroller and Auditor General has conducted any audit specifically examining value-for-money, expenditure controls or financial governance under the treatment abroad scheme since 2020. [39195/26]
Ken O'Flynn Written 26 May 2026 · to Health
1294. Deputy Ken O'Flynn asked the Minister for Health whether the HSE maintains data comparing the cost of treatments funded abroad under the treatment abroad scheme against estimated equivalent domestic treatment costs. [39196/26]
Ken O'Flynn Written 26 May 2026 · to Health
1295. Deputy Ken O'Flynn asked the Minister for Health whether the treatment abroad scheme is currently subject to any formal risk assessment relating to expenditure growth, cost escalation, or dependency on overseas treatment provision. [39197/26]
Ken O'Flynn Written 26 May 2026 · to Health
1296. Deputy Ken O'Flynn asked the Minister for Health whether any external consultancy, economic review, or health technology assessment has been commissioned in relation to expenditure under the treatment abroad scheme since 2020. [39198/26]
Ken O'Flynn Written 26 May 2026 · to Health
1297. Deputy Ken O'Flynn asked the Minister for Health whether the HSE maintains any central register of adverse clinical outcomes, complications, revision procedures, hospital readmissions or patient safety incidents arising from treatments funded under the treatment abroad scheme.; and if she will make a statement on the matter. [39199/26]
Ken O'Flynn Written 26 May 2026 · to Health
1298. Deputy Ken O'Flynn asked the Minister for Health whether the HSE receives any routine post-treatment clinical outcome reports from overseas providers in respect of procedures funded under the treatment abroad scheme. [39200/26]
Ken O'Flynn Written 26 May 2026 · to Health
1299. Deputy Ken O'Flynn asked the Minister for Health whether any structured patient follow-up programme exists for persons returning to Ireland following procedures funded under the treatment abroad scheme. [39201/26]
Ken O'Flynn Written 26 May 2026 · to Health
1300. Deputy Ken O'Flynn asked the Minister for Health whether the Department or HSE has carried out any review of long-term patient outcomes associated with procedures funded under the treatment abroad scheme since 2020. [39202/26]
Ken O'Flynn Written 26 May 2026 · to Health
1301. Deputy Ken O'Flynn asked the Minister for Health whether any value-for-money framework exists comparing the clinical outcomes and costs associated with overseas procedures funded under the treatment abroad scheme against equivalent treatment pathways domestically. [39203/26]
Ken O'Flynn Written 26 May 2026 · to Health
1302. Deputy Ken O'Flynn asked the Minister for Health whether the HSE maintains any provider-level performance monitoring system in respect of overseas hospitals or clinics receiving treatment abroad scheme referrals. [39204/26]
Ken O'Flynn Written 26 May 2026 · to Health
1303. Deputy Ken O'Flynn asked the Minister for Health whether any formal patient safety governance framework exists specifically governing procedures funded under the treatment abroad scheme. [39205/26]
Ken O'Flynn Written 26 May 2026 · to Health
1304. Deputy Ken O'Flynn asked the Minister for Health the number of complaints, adverse incident reports, legal claims or clinical governance concerns associated with procedures funded under the treatment abroad scheme since 2020. [39206/26]
Ken O'Flynn Written 26 May 2026 · to Health
1305. Deputy Ken O'Flynn asked the Minister for Health whether the Department has sought legal advice regarding governance and duty-of-care obligations arising from State-funded overseas medical procedures where no structured outcomes monitoring system exists. [39207/26]
Ken O'Flynn Written 26 May 2026 · to Health
1306. Deputy Ken O'Flynn asked the Minister for Health whether the absence of structured clinical outcome monitoring under the treatment abroad scheme has been identified on any Departmental or HSE risk register. [39208/26]
Ken O'Flynn Written 26 May 2026 · to Health
1307. Deputy Ken O'Flynn asked the Minister for Health whether the HSE maintains a category-specific expenditure breakdown for procedures funded under the treatment abroad scheme; and if so, whether gender affirmation surgeries are separately identifiable within those records. [39210/26]
Ken O'Flynn Written 26 May 2026 · to Health
1308. Deputy Ken O'Flynn asked the Minister for Health whether any value-for-money assessment has been conducted regarding overseas gender affirmation surgeries funded under the treatment abroad scheme since 2020. [39211/26]
Ken O'Flynn Written 26 May 2026 · to Health
1309. Deputy Ken O'Flynn asked the Minister for Health whether any risk assessment, governance review or assurance process has been undertaken specifically relating to overseas gender affirmation surgery approvals under the treatment abroad scheme. [39212/26]
Ken O'Flynn Written 26 May 2026 · to Health
1310. Deputy Ken O'Flynn asked the Minister for Health whether the Comptroller and Auditor General has ever examined category-specific overseas treatment expenditure under the treatment abroad scheme; and if so, to provide details. [39213/26]
Ken O'Flynn Written 26 May 2026 · to Health
1311. Deputy Ken O'Flynn asked the Minister for Health whether the Department of Health receives specialty-specific approval or expenditure data from the treatment abroad scheme during quarterly oversight meetings. [39214/26]
Ken O'Flynn Written 26 May 2026 · to Health
1312. Deputy Ken O'Flynn asked the Minister for Health whether any national clinical governance framework exists governing referrals for overseas gender affirmation surgeries funded through the treatment abroad scheme. [39215/26]
Ken O'Flynn Written 26 May 2026 · to Health
1313. Deputy Ken O'Flynn asked the Minister for Health whether the HSE records the total annual number of gender affirmation surgery applications approved under the treatment abroad scheme since 2020, by year. [39216/26]